Type 2 Diabetes

Subtle elevations in fasting glucose and triglycerides associated with developing type 2 diabetes.

Study conducted in Germany demonstrates all-cause mortality to be doubled in patients with both diagnosed and undiagnosed type 2 diabetes.

T2D diagnosed within last 6 years may be able to achieve remission if substantial weight loss is achieved.

Costs vs. Outcomes for Patients With Type 2 Diabetes: The issue of cost in healthcare is a central point in the discussion of the future of medicine. While much is made of the cost of end-of-life care, many of the dollars spent yearly are focused on the treatment of chronic diseases like diabetes. The estimated yearly cost of diabetes care was $245 billion in the U.S. in 2012, the last year for which numbers have been reported. $50 billion of that was related to prescription drug purchases.

Patients who skipped initial treatment with metformin and were instead started on second-line antihyperglycemic medication more likely to need dual therapy or insulin to control T2.

Part 1 of a four part series on a framework developed by Dr. Bradley Eilerman and Len Testa for recommending medications for treating patients with type 2 diabetes.

A thousand times today, in offices all over America, hospital patients will be diagnosed with type 2 diabetes. When that happens, a healthcare provider has to make a treatment decision of enormous complexity, often with partial information to go on, and in the span of just a few minutes.

The answer comes from a mediation analysis of the EMPA-REG OUTCOME Trial.

Patients are not seeing the expected results because of medication adherence.

Getting type 2 diabetes at an early age increases risk for all diabetes complications, including death.

How best to decide whether to use one or a combination of the new treatments and individualize the treatment for your patients.